Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

106 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The many faces of interleukin-6: the role of IL-6 in inflammation, vasculopathy, and fibrosis in systemic sclerosis.
Barnes TC, Anderson ME, Moots RJ. Barnes TC, et al. Int J Rheumatol. 2011;2011:721608. doi: 10.1155/2011/721608. Epub 2011 Sep 20. Int J Rheumatol. 2011. PMID: 21941555 Free PMC article.
Bone turnover in untreated polymyalgia rheumatica.
Barnes TC, Daroszewska A, Fraser WD, Bucknall RC. Barnes TC, et al. Rheumatology (Oxford). 2004 Apr;43(4):486-90. doi: 10.1093/rheumatology/keh072. Epub 2004 Jan 13. Rheumatology (Oxford). 2004. PMID: 14722347
Neutrophil-derived reactive oxygen species in SSc.
Barnes TC, Anderson ME, Edwards SW, Moots RJ. Barnes TC, et al. Rheumatology (Oxford). 2012 Jul;51(7):1166-9. doi: 10.1093/rheumatology/ker520. Epub 2012 Feb 20. Rheumatology (Oxford). 2012. PMID: 22351900
Endothelial activation and apoptosis mediated by neutrophil-dependent interleukin 6 trans-signalling: a novel target for systemic sclerosis?
Barnes TC, Spiller DG, Anderson ME, Edwards SW, Moots RJ. Barnes TC, et al. Ann Rheum Dis. 2011 Feb;70(2):366-72. doi: 10.1136/ard.2010.133587. Epub 2010 Nov 10. Ann Rheum Dis. 2011. PMID: 21068092 Free PMC article.
Relative α₁-anti-trypsin deficiency in systemic sclerosis.
Barnes TC, Cross A, Anderson ME, Edwards SW, Moots RJ. Barnes TC, et al. Rheumatology (Oxford). 2011 Aug;50(8):1373-8. doi: 10.1093/rheumatology/ker123. Epub 2011 Mar 30. Rheumatology (Oxford). 2011. PMID: 21454304 Free PMC article.
Baseline vWF factor predicts the development of elevated pulmonary artery pressure in systemic sclerosis.
Barnes T, Gliddon A, Doré CJ, Maddison P, Moots RJ; QUINs Trial Study Group. Barnes T, et al. Rheumatology (Oxford). 2012 Sep;51(9):1606-9. doi: 10.1093/rheumatology/kes068. Epub 2012 May 16. Rheumatology (Oxford). 2012. PMID: 22596213 Free PMC article.
Targeting nanomedicines in the treatment of rheumatoid arthritis: focus on certolizumab pegol.
Barnes T, Moots R. Barnes T, et al. Int J Nanomedicine. 2007;2(1):3-7. doi: 10.2147/nano.2007.2.1.3. Int J Nanomedicine. 2007. PMID: 17722505 Free PMC article. Review.
A case of relapsing and refractory catastrophic anti-phospholipid syndrome successfully managed with eculizumab, a complement 5 inhibitor.
Wig S, Chan M, Thachil J, Bruce I, Barnes T. Wig S, et al. Rheumatology (Oxford). 2016 Feb;55(2):382-4. doi: 10.1093/rheumatology/kev371. Epub 2015 Oct 15. Rheumatology (Oxford). 2016. PMID: 26472567 No abstract available.
Cytokine medicines in clinical practice: current issues.
Barnes T, Moots RJ, Goodacre J. Barnes T, et al. Cytokine. 2005 Oct 21;32(2):62-6. doi: 10.1016/j.cyto.2005.07.010. Epub 2005 Sep 26. Cytokine. 2005. PMID: 16188452 Review.
Changes underlying the dynamic contrast-enhanced MRI response to treatment in rheumatoid arthritis.
Hodgson RJ, Barnes T, Connolly S, Eyes B, Campbell RS, Moots R. Hodgson RJ, et al. Skeletal Radiol. 2008 Mar;37(3):201-7. doi: 10.1007/s00256-007-0408-1. Epub 2007 Dec 5. Skeletal Radiol. 2008. PMID: 18058095
106 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback